Currently, a growing body of evidence demonstrates that Foxo3 aberrantly expresses in several cancers, including breast cancer [31], lung cancer [12], and esophageal squamous cell cancer progression [10]. The gene discussed is FOXO3; the disease is breast carcinoma.